An immunotherapy-containing regimen improves event-free survival in a phase 3 trial of patients with locally advanced rectal ...

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

In a recent clinical trial, a low dose of aspirin reduced the risk of colon and rectal cancer recurrence by half in patients whose tumors carried a specific genetic mutation. Just 160 milligrams of ...

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world ...

Baseline ctDNA negativity or on-treatment clearance in anal squamous cell carcinoma correlated with 100% one-year overall survival and no local recurrence, whereas post-treatment positivity predicted ...

A landmark Viewpoint argues that the gap between ctDNA's prognostic power and clinical utility reflects misalignment of ...

Among patients who had undergone curative surgery for primary colorectal cancer, the screening methods of computed tomography and carcinoembryonic antigen each provided an improved rate of surgical ...

For Japanese people, colorectal cancer is one of the most familiar types of cancer.According to statistics from the National Cancer Center, colorectal cancer is known as one of the most common cancers ...

Berberine significantly reduced adenoma recurrence and colorectal neoplasm occurrence in a 6-year follow-up study of nearly 800 patients post-polypectomy. The study found that berberine's ...

Safety and Efficacy Study of Ablative Radiation Therapy for Large Liver Metastases Invading Into the Inferior Vena Cava and Heart Patients with CRC who develop locoregional recurrence exhibit a ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...